These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12193476)

  • 1. c-Jun NH(2)-terminal kinase pathway in growth-promoting effect of the G protein-coupled receptor cholecystokinin B receptor: a protein kinase C/Src-dependent-mechanism.
    Dehez S; Bierkamp C; Kowalski-Chauvel A; Daulhac L; Escrieut C; Susini C; Pradayrol L; Fourmy D; Seva C
    Cell Growth Differ; 2002 Aug; 13(8):375-85. PubMed ID: 12193476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatidylinositol-3 kinase is distinctively required for mu-, but not kappa-opioid receptor-induced activation of c-Jun N-terminal kinase.
    Kam AY; Chan AS; Wong YH
    J Neurochem; 2004 Apr; 89(2):391-402. PubMed ID: 15056283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCKA receptor activation stimulates p130(Cas) tyrosine phosphorylation, translocation, and association with Crk in rat pancreatic acinar cells.
    Ferris HA; Tapia JA; García LJ; Jensen RT
    Biochemistry; 1999 Feb; 38(5):1497-508. PubMed ID: 9931015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A direct interaction between JNK1 and CrkII is critical for Rac1-induced JNK activation.
    Girardin SE; Yaniv M
    EMBO J; 2001 Jul; 20(13):3437-46. PubMed ID: 11432831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor differentially augments G(i)-mediated stimulation of c-Jun N-terminal kinase activity.
    Chan AS; Wong YH
    Br J Pharmacol; 2004 Jun; 142(4):635-46. PubMed ID: 15172963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective involvement of p130Cas/Crk/Pyk2/c-Src in endothelin-1-induced JNK activation.
    Kodama H; Fukuda K; Takahashi E; Tahara S; Tomita Y; Ieda M; Kimura K; Owada KM; Vuori K; Ogawa S
    Hypertension; 2003 Jun; 41(6):1372-9. PubMed ID: 12719447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotropin-releasing hormone induces apoptosis of prostate cancer cells: role of c-Jun NH2-terminal kinase, protein kinase B, and extracellular signal-regulated kinase pathways.
    Kraus S; Levy G; Hanoch T; Naor Z; Seger R
    Cancer Res; 2004 Aug; 64(16):5736-44. PubMed ID: 15313914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional activation of c-Fos by constitutively active Galpha(16)QL through a STAT1-dependent pathway.
    Lo RK; Wong YH
    Cell Signal; 2006 Dec; 18(12):2143-53. PubMed ID: 16781847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relaxin family peptide receptor 3 activates extracellular signal-regulated kinase 1/2 through a protein kinase C-dependent mechanism.
    van der Westhuizen ET; Werry TD; Sexton PM; Summers RJ
    Mol Pharmacol; 2007 Jun; 71(6):1618-29. PubMed ID: 17351017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Met-induced JNK activation is mediated by the adapter protein Crk and correlates with the Gab1 - Crk signaling complex formation.
    Garcia-Guzman M; Dolfi F; Zeh K; Vuori K
    Oncogene; 1999 Dec; 18(54):7775-86. PubMed ID: 10618718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal peptide signalling in health and disease.
    Rozengurt E; Guha S; Sinnett-Smith J
    Eur J Surg Suppl; 2002; (587):23-38. PubMed ID: 16144198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells.
    Zhang Q; Thomas SM; Xi S; Smithgall TE; Siegfried JM; Kamens J; Gooding WE; Grandis JR
    Cancer Res; 2004 Sep; 64(17):6166-73. PubMed ID: 15342401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wortmannin-sensitive activation of p70S6-kinase and MAP-kinase by the G protein-coupled receptor, G/CCKB.
    Seva C; Kowalski-Chauvel A; Daulhac L; Barthez C; Vaysse N; Pradayrol L
    Biochem Biophys Res Commun; 1997 Sep; 238(1):202-6. PubMed ID: 9299479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kappa-opioid receptor signals through Src and focal adhesion kinase to stimulate c-Jun N-terminal kinases in transfected COS-7 cells and human monocytic THP-1 cells.
    Kam AY; Chan AS; Wong YH
    J Pharmacol Exp Ther; 2004 Jul; 310(1):301-10. PubMed ID: 14996948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1.
    Guha S; Lunn JA; Santiskulvong C; Rozengurt E
    Cancer Res; 2003 May; 63(10):2379-87. PubMed ID: 12750255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrin-induced DNA synthesis requires p38-MAPK activation via PKC/Ca(2+) and Src-dependent mechanisms.
    Dehez S; Daulhac L; Kowalski-Chauvel A; Fourmy D; Pradayrol L; Seva C
    FEBS Lett; 2001 May; 496(1):25-30. PubMed ID: 11343700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gq-mediated activation of c-Jun N-terminal kinase by the gastrin-releasing peptide-preferring bombesin receptor is inhibited upon costimulation of the Gs-coupled dopamine D1 receptor in COS-7 cells.
    Chan AS; Wong YH
    Mol Pharmacol; 2005 Nov; 68(5):1354-64. PubMed ID: 16061771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Src protein tyrosine kinase activity is required for muscarinic receptor-mediated DNA synthesis and neurogenesis via ERK1/2 and c-AMP-responsive element-binding protein signaling in neural precursor cells.
    Zhao WQ; Alkon DL; Ma W
    J Neurosci Res; 2003 May; 72(3):334-42. PubMed ID: 12692900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p130Cas interacts with estrogen receptor alpha and modulates non-genomic estrogen signaling in breast cancer cells.
    Cabodi S; Moro L; Baj G; Smeriglio M; Di Stefano P; Gippone S; Surico N; Silengo L; Turco E; Tarone G; Defilippi P
    J Cell Sci; 2004 Mar; 117(Pt 8):1603-11. PubMed ID: 15020686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.